These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12956930

  • 1. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH, Milekhin V, Zhang H, Huang HZ.
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [Abstract] [Full Text] [Related]

  • 2. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS, Nogueira-Martins MF, Silva HT, Pestana JO, Bueno V.
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [Abstract] [Full Text] [Related]

  • 3. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 4. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S, Rodriguez-Barbosa JI, Pabst O, Beckmann JH, Brinkmann V, Förster R, Hoffmann MW.
    Transplant Proc; 2005 Jan 18; 37(1):114-5. PubMed ID: 15808565
    [Abstract] [Full Text] [Related]

  • 5. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344
    [Abstract] [Full Text] [Related]

  • 6. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation].
    Xiong HB, Huang ZF, Ye QF, Xia SS.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 20; 32(1):41-6. PubMed ID: 17344585
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L, Wang C, He X, Shang W, Bi Y, Wang D.
    Microsurgery; 2007 Feb 20; 27(4):300-4. PubMed ID: 17477424
    [Abstract] [Full Text] [Related]

  • 8. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 20; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 9. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K.
    Transplant Proc; 1996 Apr 20; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract] [Full Text] [Related]

  • 10. [Study the mechanisms and inducing transplantation immune tolerance of FTY720].
    Zhang L, Zhu T, Sun EW, Shen SQ, Guo H, Min ZL, Chen ZH.
    Zhonghua Wai Ke Za Zhi; 2003 Oct 20; 41(10):773-7. PubMed ID: 14766054
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    J Immunol; 1998 May 15; 160(10):5037-44. PubMed ID: 9590253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
    Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Kusafuka T, Fukuzawa M.
    Transplant Proc; 2006 Nov 15; 38(9):3058-60. PubMed ID: 17112899
    [Abstract] [Full Text] [Related]

  • 16. Significant prolongation of orthotopic corneal-graft survival in FTY720-treated mice.
    Zhang EP, Müller A, Ignatius R, Hoffmann F.
    Transplantation; 2003 Nov 27; 76(10):1511-3. PubMed ID: 14657695
    [Abstract] [Full Text] [Related]

  • 17. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T, Okada A.
    Transplantation; 2003 May 15; 75(9):1469-74. PubMed ID: 12792499
    [Abstract] [Full Text] [Related]

  • 18. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2000 Jun 15; 8(2):115-24. PubMed ID: 11005317
    [Abstract] [Full Text] [Related]

  • 19. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S, Enosawa S, Kakefuda T, Amemiya H, Hoshino Y, Chiba K.
    Transplant Proc; 1996 Jun 15; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 15; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.